Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson purchased 1,666,666 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were acquired at an average price of A$0.01 ($0.01) per share, with a total value of A$14,999.99 ($9,316.77).
Percheron Therapeutics Price Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- What Do S&P 500 Stocks Tell Investors About the Market?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
- Utilities Stocks Explained – How and Why to Invest in Utilities
- These 3 Retail Stocks Can Keep Winning in 2025
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
